HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,144,000 | – | 400,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| York Capital Management Global Advisors, LLC | 2,291,397 | $16,177,000 | 4.71% |
| Endowment Wealth Management, Inc. | 96,618 | $682,000 | 0.72% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 36,171 | $255,000 | 0.24% |
| Prescott General Partners LLC | 625,100 | $4,413,000 | 0.20% |
| CenterBook Partners LP | 45,752 | $323,000 | 0.12% |
| Gladstone Institutional Advisory LLC | 144,867 | $1,023 | 0.07% |
| Exos Asset Management LLC | 18,609 | $131,000 | 0.06% |
| Sciencast Management LP | 26,300 | $182,000 | 0.04% |
| Y-Intercept (Hong Kong) Ltd | 17,125 | $121,000 | 0.03% |
| Kovack Advisors, Inc. | 31,500 | $222,000 | 0.02% |